UnitedHealth Group Incorporated (UNH) Holdings Boosted by Honeywell International Inc.
Honeywell International Inc. boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 215,400 shares of the healthcare conglomerate’s stock after buying an additional 400 shares during the quarter. UnitedHealth Group accounts for approximately 1.5% of Honeywell International Inc.’s holdings, making the stock its 13th biggest holding. Honeywell International Inc.’s holdings in UnitedHealth Group were worth $39,939,000 at the end of the most recent quarter.
A number of other hedge funds have also recently modified their holdings of UNH. Waldron LP lifted its holdings in UnitedHealth Group by 153.1% in the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after buying an additional 3,487 shares in the last quarter. Welch & Forbes LLC lifted its holdings in UnitedHealth Group by 5.9% in the 1st quarter. Welch & Forbes LLC now owns 1,822 shares of the healthcare conglomerate’s stock worth $299,000 after buying an additional 102 shares in the last quarter. Old Mutual Global Investors UK Ltd. acquired a new position in UnitedHealth Group in the 1st quarter worth $109,807,000. Reynders McVeigh Capital Management LLC lifted its holdings in UnitedHealth Group by 6.0% in the 1st quarter. Reynders McVeigh Capital Management LLC now owns 1,546 shares of the healthcare conglomerate’s stock worth $254,000 after buying an additional 87 shares in the last quarter. Finally, Shine Investment Advisory Services Inc. acquired a new position in UnitedHealth Group in the 1st quarter worth $247,000. Hedge funds and other institutional investors own 86.19% of the company’s stock.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The shares were sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock valued at $14,981,909 in the last 90 days. Corporate insiders own 0.89% of the company’s stock.
A number of equities analysts have commented on the stock. Barclays PLC boosted their price objective on shares of UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price objective on the stock in a report on Thursday, September 21st. Cowen and Company reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, July 14th. Leerink Swann reiterated an “outperform” rating on shares of UnitedHealth Group in a report on Friday, June 9th. Finally, Jefferies Group LLC reiterated a “buy” rating and issued a $215.00 price objective on shares of UnitedHealth Group in a report on Friday, August 18th. Three investment analysts have rated the stock with a hold rating and twenty-three have issued a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $203.59.
UnitedHealth Group Incorporated (NYSE:UNH) opened at 197.90 on Friday. UnitedHealth Group Incorporated has a 52-week low of $133.03 and a 52-week high of $200.76. The firm has a 50-day moving average of $196.20 and a 200 day moving average of $183.34. The company has a market cap of $191.34 billion, a PE ratio of 23.77 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.38 by $0.08. The firm had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. UnitedHealth Group had a net margin of 4.32% and a return on equity of 21.52%. The company’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter last year, the company posted $1.96 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. This represents a $3.00 annualized dividend and a yield of 1.52%. The ex-dividend date was Thursday, September 7th. UnitedHealth Group’s payout ratio is presently 35.13%.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.